Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2020

Earnings Per Share [Abstract]

Summary Of Anti-Dilutive Shares

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to Ginkgo Bioworks, Inc. common stockholders for the periods indicated because including them would have been anti-dilutive:

	Year Ended December 31,
	2020		2019
Warrants to purchase common stock		1,020,187		1,020,187
Outstanding stock options		33,354,871		35,276,812
Unvested RSUs		124,932,207		70,119,944
Unvested RSAs		419,049		675,887